MAPT and Alzheimer disease: Our large cohort is well-characterized in terms of neuropathology; we exclude any cases with neuropathological diagnoses of FTLD, ALS, or non-AD tauopathies, such that our results are specific to p-tau and pTDP-43 in the context of AD and LATE-NC.